-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Head to Head Review: Smart for Life (NASDAQ:SMFL) Versus Jinhua Marine Biological (OTCMKTS:JNMB)
Head to Head Review: Smart for Life (NASDAQ:SMFL) Versus Jinhua Marine Biological (OTCMKTS:JNMB)
Smart for Life (NASDAQ:SMFL – Get Rating) and Jinhua Marine Biological (OTCMKTS:JNMB – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.
Earnings and Valuation
This table compares Smart for Life and Jinhua Marine Biological's top-line revenue, earnings per share and valuation.
Get Smart for Life alerts:| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Smart for Life | $9.02 million | 0.92 | -$7.77 million | N/A | N/A |
| Jinhua Marine Biological | N/A | N/A | N/A | N/A | N/A |
Jinhua Marine Biological has lower revenue, but higher earnings than Smart for Life.
Analyst Recommendations
This is a breakdown of recent recommendations for Smart for Life and Jinhua Marine Biological, as provided by MarketBeat.com.| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Smart for Life | 0 | 0 | 1 | 0 | 3.00 |
| Jinhua Marine Biological | 0 | 0 | 0 | 0 | N/A |
Smart for Life currently has a consensus price target of $8.00, indicating a potential upside of 3,375.24%. Given Smart for Life's higher possible upside, equities analysts plainly believe Smart for Life is more favorable than Jinhua Marine Biological.
Institutional and Insider Ownership
0.4% of Smart for Life shares are held by institutional investors. 45.1% of Smart for Life shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Smart for Life and Jinhua Marine Biological's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Smart for Life | -139.56% | -1,377.59% | -94.78% |
| Jinhua Marine Biological | N/A | N/A | N/A |
Summary
Smart for Life beats Jinhua Marine Biological on 5 of the 8 factors compared between the two stocks.
About Smart for Life
(Get Rating)
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements; dietary supplements; nutritional supplements for athletes and active lifestyle consumers comprising powders, tablets, and soft gels; and various nutritional supplements. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Miami, Florida.
About Jinhua Marine Biological
(Get Rating)
Jinhua Marine Biological (USA), Inc. develops allopelagic materials, biological medicines, pesticides, environmental protection products, and products for the home. It offers health products, including Xiduoan, which is used for strengthening and adjusting the immune system. The company also introduces advanced wastewater treatment technology, as well as develops environmental protection projects, including industry/urban wastewater treatment. This business was pursued in three areas: the development, manufacture, distribution and sale of ERGOS Systems directly by the Company; consulting services, and the delivery of marketing and other services to ERGOS network providers.
Receive News & Ratings for Smart for Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smart for Life and related companies with MarketBeat.com's FREE daily email newsletter.
Smart for Life (NASDAQ:SMFL – Get Rating) and Jinhua Marine Biological (OTCMKTS:JNMB – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.
智慧生命 (NASDAQ: SMFL — 獲取評級) 和金華海洋生物學 (OTCMKTS: JNMB — 獲得評級) 都是醫療公司, 但哪個是更好的股票?我們將根據兩家公司的股息，估值，分析師建議，盈利能力，風險，收益和機構所有權的實力進行比較。
Earnings and Valuation
收益及估值
This table compares Smart for Life and Jinhua Marine Biological's top-line revenue, earnings per share and valuation.
本表比較了智慧生命和金華海洋生物的頂級收入、每股收益和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Smart for Life | $9.02 million | 0.92 | -$7.77 million | N/A | N/A |
| Jinhua Marine Biological | N/A | N/A | N/A | N/A | N/A |
| 總收入 | 價格/銷售比率 | 淨收入 | 每股盈利 | 市盈比率 | |
| 智慧生活 | 九百零二萬元 | 0.92 | -777 萬美元 | N/A | N/A |
| 金華海洋生物 | N/A | N/A | N/A | N/A | N/A |
Jinhua Marine Biological has lower revenue, but higher earnings than Smart for Life.
金華海洋生物的收入較低，但收益高於智能生活。
Analyst Recommendations
分析師推薦
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Smart for Life | 0 | 0 | 1 | 0 | 3.00 |
| Jinhua Marine Biological | 0 | 0 | 0 | 0 | N/A |
| 銷售評級 | 保留評分 | 購買評級 | 強大的買入評級 | 評級分數 | |
| 智慧生活 | 0 | 0 | 1 | 0 | 3.00 |
| 金華海洋生物 | 0 | 0 | 0 | 0 | N/A |
Smart for Life currently has a consensus price target of $8.00, indicating a potential upside of 3,375.24%. Given Smart for Life's higher possible upside, equities analysts plainly believe Smart for Life is more favorable than Jinhua Marine Biological.
智慧生活目前的共識價格目標為 8.00 美元，表明潛在的上行空間為 3,375.24％。鑑於 Smart 為生活的可能較高的上行空間，股票分析師清楚地認為智能生活比金華海洋生物更有利。
Institutional and Insider Ownership
機構和內幕所有權
0.4% of Smart for Life shares are held by institutional investors. 45.1% of Smart for Life shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
0.4% 的智慧生活股份由機構投資者持有。45.1% 的智慧生活股份由內部人士持有。強大的機構所有權表明，對沖基金，大型資金經理和捐贈基金認為股票長期的表現將優於市場。
Profitability
盈利
This table compares Smart for Life and Jinhua Marine Biological's net margins, return on equity and return on assets.
本表比較「智慧生命」和「金華海洋生物」的淨利潤率、股本回報率及資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Smart for Life | -139.56% | -1,377.59% | -94.78% |
| Jinhua Marine Biological | N/A | N/A | N/A |
| 淨利潤 | 權益回報率 | 資產回報率 | |
| 智慧生活 | -139.56% | -1,377.59% | -94.78% |
| 金華海洋生物 | N/A | N/A | N/A |
Summary
摘要
Smart for Life beats Jinhua Marine Biological on 5 of the 8 factors compared between the two stocks.
兩隻股票之間的 8 個因素中有 5 個，智慧生命勝過金華海洋生物學。
About Smart for Life
關於智慧生活
(Get Rating)
(取得評分)
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements; dietary supplements; nutritional supplements for athletes and active lifestyle consumers comprising powders, tablets, and soft gels; and various nutritional supplements. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Miami, Florida.
Smart Fin Life, Inc. 在美國和國際上收購，開發，製造，經營，銷售營養品和相關產品，並銷售營養品和相關產品。它提供天然健康和保健餐替代產品, 包括營養棒, 餅乾, 湯和奶昔, 維生素, 和補充劑; 膳食補充劑; 運動員營養補充劑和積極的生活方式消費者包括粉末, 片劑, 和軟凝膠; 和各種營養補充劑.它通過在線市場平台銷售其產品。該公司以前稱為博恩·桑特集團有限公司，並於 2021 年 8 月更名為智能生活公司。智慧生活公司成立於 2002 年，總部設在佛羅里達州的邁阿密市。
About Jinhua Marine Biological
關於金華海洋生物
(Get Rating)
(取得評分)
Jinhua Marine Biological (USA), Inc. develops allopelagic materials, biological medicines, pesticides, environmental protection products, and products for the home. It offers health products, including Xiduoan, which is used for strengthening and adjusting the immune system. The company also introduces advanced wastewater treatment technology, as well as develops environmental protection projects, including industry/urban wastewater treatment. This business was pursued in three areas: the development, manufacture, distribution and sale of ERGOS Systems directly by the Company; consulting services, and the delivery of marketing and other services to ERGOS network providers.
金華海洋生物 (美國) 股份有限公司為家庭開發的同種材料、生物藥品、農藥、環保產品和產品。它提供保健產品，包括西多安，用於增強和調節免疫系統。公司還引進先進的廢水處理技術，並開發環保項目，包括工業/城市廢水處理。該業務在三個領域進行：公司直接開發，製造，分銷和銷售 ERGOS Systems；諮詢服務以及向 ERGOS 網絡提供商提供營銷和其他服務。
Receive News & Ratings for Smart for Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smart for Life and related companies with MarketBeat.com's FREE daily email newsletter.
接收智慧生活日常的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收有關智能生活和相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧